LMM

You might also like

You are on page 1of 1

LMM

Moreover, the efficacy of this class of drugs in severe dementia is unclear, although behavioral symptom
improvement was identified for galantamine (Institute for Quality and Efficiency in Healthcare, 2014). A fourth
drug for the treatment of cognitive impairment, memantine, has a different mode of action and is well
tolerated, but evidence for its efficacy is limited to people with moderate to severe dementia. Cholinesterase
inhibitors (ChEIs) and memantine are less efficacious in vascular dementia than other forms. ChEIs and
memantine’s efficacy in the treatment of behavioral disturbances is not established; manufacturer-sponsored
licensing trials and post hoc analyses indicate small improvements.

You might also like